Medical device recalls Moderate risk

Randox Laboratories Ltd. recalls RX Series Copper (Cu) Assay Ref. Number CU2340

Recall date
November 29, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0992-2024
FDA classification
Class II
Brand / firm
Randox Laboratories Ltd.
Sold / distributed
US Nationwide distribution in the states of SC and OK.

Why it was recalled

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

RX Series Copper (Cu) Assay Ref. Number CU2340

Get recall alerts

Free email alert whenever Randox Laboratories Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Randox Laboratories Ltd.